Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by WARING, R. H.
Right arrow Articles by EMERY, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WARING, R. H.
Right arrow Articles by EMERY, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 British Society for Rheumatology

other

THE GENETIC BASIS OF RESPONSES TO DRUGS—A RHEUMATOLOGICAL PERSPECTIVE

R. H. WARING*, and P. EMERY{dagger}

*School of Biochemistry, The University of Birmingham Edgbaston, Birmingham B15 2TT
{dagger}Department of Rheumatology, The University of Birmingham Edgbaston, Birmingham B15 2TT

Correspondence to: Correspondence to R. H. Waring

The wide individual variations seen in all metabolic pathways which have been examined largely explain differences in drug dose response and toxicity. In some cases, distinct sub-sets occur where the enzyme activity is markedly different from that in the rest of the population (genetic polymorphism). Studies on isolated enzymes and use of restriction fragment length polymorphisms have in some cases helped to elucidate the relevant molecular biology. However, the lack of certain concordance between genotype and phenotype has shown that many questions remain unanswered. As more information becomes available at the molecular level, it may be easier to gain an understanding of the endogenous biochemistry which underlies the human condition. Either genotyping or phenotyping may then be used to predict potential drug side-effects or clinical outcomes.

KEY WORDS: Pharmacogenetics, Drugs, Polymorphisms, Rheumatology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
C. Siva, W. M. Yokoyama, and H. L. McLeod
Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field
Rheumatology, November 1, 2002; 41(11): 1273 - 1279.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.